Hai Lin

Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells

Xiaojia Niu, Jianyun Zhao, Jun Ma et al. · Clinical Cancer Research · 2016 · 233 citations · Full text

Inhibition of Bcl-2 Synergistically Enhances the Antileukemic Activity of Midostaurin and Gilteritinib in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia

Jun Ma, Xinan Qiao, Tristan Knight et al. · Clinical Cancer Research · 2019 · 172 citations · Full text

Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells

Daniel A Luedtke, Xiaojia Niu, Yihang Pan et al. · Signal Transduction and Targeted Therapy · 2017 · 123 citations · Full text

A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations

Liang Zhou, Yuesheng Zhang, Shucheng Chen et al. · Leukemia · 2014 · 77 citations · Full text

Hematological Malignancy, Wee1 Inhibitor Azd1775, Medicine +8

Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia

Xinyu Li, Yongwei Su, Gerard J. Madlambayan et al. · Haematologica · 2019 · 65 citations · Full text